Table 2. Effect of the NOD1 agonist iE-DAP on CXCL8 release by HMVEC and HPASM.

	CXCL8 release (% control)
	HMVEC	HPASM
Control	100±0	100±0
iE-DAP 10 µg/ml	885.6±41.5*	126.8±2.9*

HMVEC and HPASM were cultured for 24 hours in 96 well plates with media alone or iE-DAP 10 µg/ml. Normalised results expressed as mean percentage change from control ± SEM; 12 (HMVEC) or 8 (HPASM). Results were analysed by one-sample t-test (*P<0.05).